GAO: FDA’s Overseas Inspections Hurt by Job Vacancies

Drug GMP Report
The FDA has made great strides in conducting international inspections but still remains understaffed, according to the government’s official watchdog, during a time when the agency has begun to inspect more sites overseas than within the U.S.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00